{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:41:19Z","timestamp":1779165679266,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,22]]},"DOI":"10.7759\/cureus.72118","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T12:50:11Z","timestamp":1729601411000},"source":"Crossref","is-referenced-by-count":1,"title":["Assessing the Effectiveness and Safety of Combination Diuretic Therapy in Heart Failure: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Rebecca","family":"Ayoti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Mlawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Animesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-004-0021-8","article-title":"Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry","volume":"1","author":"Yancy CW","year":"2004","unstructured":"Yancy CW, Fonarow GC. Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry. Curr Heart Fail Rep. 2004, 1:121-8. 10.1007\/s11897-004-0021-8","journal-title":"Curr Heart Fail Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.09.011","article-title":"Congestion in acute heart failure syndromes: an essential target of evaluation and treatment","volume":"119","author":"Gheorghiade M","year":"2006","unstructured":"Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006, 119:S3-S10. 10.1016\/j.amjmed.2006.09.011","journal-title":"Am J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.110933","article-title":"Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure","volume":"140","author":"Lucas C","year":"2000","unstructured":"Lucas C, Johnson W, Hamilton MA, et al.. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J. 2000, 140:840-7. 10.1067\/mhj.2000.110933","journal-title":"Am Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw383","article-title":"Erratum","volume":"39","year":"2018","unstructured":"Erratum. Eur Heart J. 2018, 39.860. 10.1093\/eurheartj\/ehw383","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.001957","article-title":"Relief and recurrence of congestion during and after hospitalization for acute heart failure: Insights from diuretic optimization strategy evaluation in acute decompensated heart failure (DOSE-AHF) and cardiorenal rescue study in acute decompensated heart failure (CARESS-HF)","volume":"8","author":"Lala A","year":"2015","unstructured":"Lala A, McNulty SE, Mentz RJ, et al.. Relief and recurrence of congestion during and after hospitalization for acute heart failure: Insights from diuretic optimization strategy evaluation in acute decompensated heart failure (DOSE-AHF) and cardiorenal rescue study in acute decompensated heart failure (CARESS-HF). Circ Heart Fail. 2015, 8:741-8. 10.1161\/CIRCHEARTFAILURE.114.001957","journal-title":"Circ Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy AP","year":"2013","unstructured":"Ambrosy AP, Pang PS, Khan S, et al.. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013, 34:835-43. 10.1093\/eurheartj\/ehs444","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens W","year":"2019","unstructured":"Mullens W, Damman K, Harjola VP, et al.. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019, 21:137-55. 10.1002\/ejhf.1369","journal-title":"Eur J Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000082314","article-title":"Long-term adaptation of renal ion transporters to chronic diuretic treatment","volume":"24","author":"Kim GH","year":"2004","unstructured":"Kim GH. Long-term adaptation of renal ion transporters to chronic diuretic treatment. Am J Nephrol. 2004, 24:595-605. 10.1159\/000082314","journal-title":"Am J Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald E","year":"2013","unstructured":"Braunwald E. Heart failure. JACC Heart Fail. 2013, 1:1-20. 10.1016\/j.jchf.2012.10.002","journal-title":"JACC Heart Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.71.2.146","article-title":"Combination diuretic treatment in severe heart failure: a randomised controlled trial","volume":"71","author":"Channer KS","year":"1994","unstructured":"Channer KS, McLean KA, Lawson-Matthew P, Richardson M. Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J. 1994, 71:146-50. 10.1136\/hrt.71.2.146","journal-title":"Br Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021, 10:89. 10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2014.03.006","article-title":"A prospective, randomized study to evaluate the efficacy of various diuretic strategies in acute decompensated heart failure","volume":"66","author":"Shah RA","year":"2014","unstructured":"Shah RA, Subban V, Lakshmanan A, et al.. A prospective, randomized study to evaluate the efficacy of various diuretic strategies in acute decompensated heart failure. Indian Heart J. 2014, 66:309-16. 10.1016\/j.ihj.2014.03.006","journal-title":"Indian Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96943-y","article-title":"Author Correction: Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial","volume":"11","author":"Piardi DS","year":"2021","unstructured":"Piardi DS, Butzke M, Mazzuca AC, et al.. Author Correction: Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial. Sci Rep. 2021, 11:17370. 10.1038\/s41598-021-96943-y","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2587","article-title":"Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics","volume":"24","author":"Mullens W","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, et al.. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics. Eur J Heart Fail. 2022, 24:1601-10. 10.1002\/ejhf.2587","journal-title":"Eur J Heart Fail"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trull\u00e0s JC","year":"2023","unstructured":"Trull\u00e0s JC, Morales-Rull JL, Casado J, et al.. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J. 2023, 44:411-21. 10.1093\/eurheartj\/ehac689","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047077","article-title":"Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF","volume":"142","author":"Jackson AM","year":"2020","unstructured":"Jackson AM, Dewan P, Anand IS, et al.. Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF. Circulation. 2020, 142:1040-54. 10.1161\/CIRCULATIONAHA.120.047077","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus J","year":"2023","unstructured":"Biegus J, Voors AA, Collins SP, et al.. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J. 2023, 44:41-50. 10.1093\/eurheartj\/ehac530","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam MA","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr, et al.. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007, 297:1319-31. 10.1001\/jama.297.12.1319","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002259","article-title":"Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials","volume":"8","author":"Felker GM","year":"2015","unstructured":"Felker GM, Mentz RJ, Adams KF, et al.. Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials. Circ Heart Fail. 2015, 8:997-1005. 10.1161\/CIRCHEARTFAILURE.115.002259","journal-title":"Circ Heart Fail"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6274.1432","article-title":"Synergistic action of metolazone with \"loop\" diuretics","volume":"282","author":"Ghose RR","year":"1981","unstructured":"Ghose RR, Gupta SK. Synergistic action of metolazone with \"loop\" diuretics. Br Med J (Clin Res Ed). 1981, 282:1432-3. 10.1136\/bmj.282.6274.1432","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker GM","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, et al.. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011, 364:797-805. 10.1056\/NEJMoa1005419","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial","volume":"9","author":"Hasselblad V","year":"2007","unstructured":"Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O'Connor CM, Califf RM, Adams KF Jr. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007, 9:1064-9. 10.1016\/j.ejheart.2007.07.011","journal-title":"Eur J Heart Fail"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v16.i5.240","article-title":"Sodium glucose cotransporter-2 inhibitors and heart disease: current perspectives","volume":"16","author":"Mondal S","year":"2024","unstructured":"Mondal S, Pramanik S, Khare VR, Fernandez CJ, Pappachan JM. Sodium glucose cotransporter-2 inhibitors and heart disease: current perspectives. World J Cardiol. 2024, 16:240-59. 10.4330\/wjc.v16.i5.240","journal-title":"World J Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(75)90041-1","article-title":"The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide","volume":"89","author":"Sigurd B","year":"1975","unstructured":"Sigurd B, Olesen KH, Wennevold A. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide. Am Heart J. 1975, 89:163-70. 10.1016\/0002-8703(75)90041-1","journal-title":"Am Heart J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014811.pub2","article-title":"Continuous infusion versus bolus injection of loop diuretics for acute heart failure","volume":"5","author":"Rasoul D","year":"2024","unstructured":"Rasoul D, Zhang J, Farnell E, et al.. Continuous infusion versus bolus injection of loop diuretics for acute heart failure. Cochrane Database Syst Rev. 2024, 5:CD014811. 10.1002\/14651858.CD014811.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34758","article-title":"Continuous infusion versus bolus injection of loop diuretics for patients with congestive heart failure: a meta-analysis","volume":"15","author":"Karedath J","year":"2023","unstructured":"Karedath J, Asif A, Tentu N, et al.. Continuous infusion versus bolus injection of loop diuretics for patients with congestive heart failure: a meta-analysis. Cureus. 2023, 15:e34758. 10.7759\/cureus.34758","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/307434-assessing-the-effectiveness-and-safety-of-combination-diuretic-therapy-in-heart-failure-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T12:50:14Z","timestamp":1729601414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/307434-assessing-the-effectiveness-and-safety-of-combination-diuretic-therapy-in-heart-failure-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.72118","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,22]]}}}